Comprehensive Stock Analysis of: Skyline Medical Inc. (NASDAQ:SKLN)


Some buy side analysts are also providing their Analysis on Skyline Medical Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Skyline Medical Inc. closed its last trading session at $3.53 with the loss of -19.55%. The Market Capitalization of the company stands at 10.82 Million. The Company has 52-week high of $6.05 and 52-week low of $0.08. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -4.05% where SMA50 and SMA200 are -14.52% and -59.82% respectively. The Company Touched its 52-Week High on Nov 22, 2016 and 52-Week Low on Aug 29, 2016.

The Relative Volume of the company is 0.19 and Average Volume (3 months) is 10.69 million. Skyline Medical Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -222.3%. The Return on Equity (ROE) value stands at -434.7%. While it’s Return on Investment (ROI) value is -116.8%.

While looking at the Stock’s Performance, Skyline Medical Inc. currently shows a Weekly Performance of 36.54%, where Monthly Performance is 21.89%, Quarterly performance is -30.73%, 6 Months performance is -15.85% and yearly performance percentage is -96.85%. Year to Date performance value (YTD perf) value is -96.14%. The Stock currently has a Weekly Volatility of 43.85% and Monthly Volatility of 27.15%.